Maghuyop, Jasel A.
HRN: 11-92-81 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/18/2022
CO-AMOXICLAV 625MG (TAB)
06/18/2022
06/25/2022
ORAL
625mg/tab
BID
S/P Episiorrhaphy PROM X 6 HRS
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes